• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: recombinant adeno-associated virus 5 vector expressing a functional human cyclic nucleotide gated channel subunit beta 1 (CNGB1) gene
Date Designated: 09/23/2024
Orphan Designation: treatment of autosomal recessive retinitis pigmentosa due to CNGB1 mutations
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
National Institutes of Health National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS)
9609 Medical Center Drive, Suite 1-E-162
Rockville, Maryland 20850
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-